Case study
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program
Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.
This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine’s switch from ROTARIX to ROTAVAC.
Authors
Languages
- Russian
Publication year
2020
Type
Case study
Categories
- Programme management
Diseases
- Rotavirus
Organisations
- PATH
Tags
- Planning, budgeting and financing
Topic references
PORTFOLIO-LESSONS
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | Professor George Armah | 2020 | Case study | English |
| Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program | PATH | 2020 | Case study | Russian |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership | 2019 | Case study | English |
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Kirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass | 2020 | Journal article | English |
| The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis | PATH, Rostropovich-Vishnevskaya Foundation, Ministry of Health, Palestine | 2021 | Report | Russian |
| The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions | PATH | 2022 | Report | English |
